Ann: Botanix Completes Enrolment of BTX 1503 Acne Patient Study, page-3

First 3 Last

Share
Profile

Follow
bernsta

4,437 Posts.

1531

18/12/17

09:41

Post #: 29698373
Share

Originally posted by beefarmer ↑

I am so disappointed in one way that BOT has sought to close off their acne trials now especially with one week to go before Christmas. Why did they choose such a pithy small sample when we all know the absolute rubbish young teenagers will be eating over the next two week period will hopefully have led their faces to look like one of those Masseur sandals with all those bumps.

Our Matt has missed a golden opportunity to show off how good BTX 1503 will be by not allowing youthful exuberance to culminate in a pimply face, one that an unfortunate Braille student could read and say - you've eaten too much fatty foods kiddy being careful not to poke the kids eyes out.

But their is light at the end of the tunnel, there is sun at the end of a rainy day, every cloud has a silver lining. You get it. Phase 2 trials in the United Stated in the first half of next year.
Ladies and gentleman I give you ninety million dollars. So long as it sucks seeds like my friends old parrot.

After that folks, we have the dermatitis study. Big pharma will be lining up and when that moment occurs, I hope Matt will be a good negotiator for us all.

Too early for an Aperol spritzer ?

Expand

I sincerely hope you have a cracking Christmas mate.

You are a ray of sunshine around here.

I'm a great northern beer drinker myself, but if you must have an Aperol Spritzer go for it.

I wish all BOT holders a merry Xmas and upcoming festive season - it's a great forum to be a part of.

BOT Price at posting: 5.9¢ Sentiment: Buy Disclosure: Held
11 Upvote

0 Great analysis

Reply

Top Stories

HAR

Haranga jumps +7% on Lincoln acquisition

Oz core inflation at 2.7%; August cut odds still unclear; ASX200 rises

HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic

NUZ

Neurizon inks $1.5M loan against R&D Tax Rebate

IXR

Ionic Rare Earths falls -7% as momentum slips on vague production update

First 3 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 15.8¢		Change -0.008(4.55%)		Mkt cap ! $308.8M

Open	High	Low	Value	Volume
16.0¢	16.3¢	15.5¢	$1.681M	10.53M

Buyers (Bids)

No.	Vol.	Price($)
88	5809699	15.5¢

Sellers (Offers)

Price($)	Vol.	No.
16.0¢	2415951	26

View Market Depth

No.	Vol.	Price($)
87	5822887	0.155
88	3753387	0.150
43	2366559	0.145
94	4169463	0.140
48	1571889	0.135

Price($)	Vol.	No.
0.160	2344526	25
0.165	3713923	25
0.170	1371669	35
0.175	2203123	24
0.180	2915684	54

Last trade - 13.50pm 30/07/2025 (20 minute delay)

BOT (ASX) Chart

Ann: Botanix Completes Enrolment of BTX 1503 Acne Patient Study, page-3

Haranga jumps +7% on Lincoln acquisition

Oz core inflation at 2.7%; August cut odds still unclear; ASX200 rises

HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic

Neurizon inks $1.5M loan against R&D Tax Rebate

Ionic Rare Earths falls -7% as momentum slips on vague production update

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Botanix Completes Enrolment of BTX 1503 Acne Patient Study, page-3

Top Stories

Haranga jumps +7% on Lincoln acquisition

Oz core inflation at 2.7%; August cut odds still unclear; ASX200 rises

HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic

Neurizon inks $1.5M loan against R&D Tax Rebate

Ionic Rare Earths falls -7% as momentum slips on vague production update

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News